10x Genomics (TXG) Interest & Investment Income (2018 - 2026)

10x Genomics has disclosed Interest & Investment Income across 9 years of filings, most recently posting $4.8 million for Q2 2026.

• In Q2 2026, Interest & Investment Income rose 12.32% year-over-year to $4.8 million; the TTM figure through Jun 2026 stood at $21.9 million (up 25.61% YoY), while the FY2025 annual figure was $20.0 million, up 5.91% from the prior year.
• Interest & Investment Income came in at $4.8 million for Q2 2026 at 10x Genomics, down from $5.0 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $6.9 million in Q4 2025 to a low of $569000.0 in Q1 2022.
• Average Interest & Investment Income over 5 years is $4.0 million, with a median of $4.4 million recorded in 2023.
• Year-over-year, Interest & Investment Income surged 5644.9% in 2022 and fell 22.17% in 2025.
• Over 5 years, Interest & Investment Income stood at $2.8 million in 2022, then soared by 63.98% to $4.6 million in 2023, then fell by 2.34% to $4.5 million in 2024, then jumped by 52.88% to $6.9 million in 2025, then sank by 30.4% to $4.8 million in 2026.
• Per Business Quant data, the three most recent Interest & Investment Income figures were $4.8 million in Q2 2026, $5.0 million in Q1 2026, and $6.9 million in Q4 2025.